doi:10.1016/j.chest.2019.12.002
Available as a weekly subcutaneous injection for diabetes (Ozempic) or weight management (Wegovy), and as a daily oral tablet (Rybelsus) for diabetes only, semaglutide has demonstrated substantial weight loss and metabolic improvements in clinical trials
I will present the effects of detector resolution within one subdetector, the Time Projection Chamber, on track level and event level data and show how this impacts the observation of a sample process, J/Psi + -
Researchers used Truveta Data from over 40,000 patients to assess whether newer GLP-1 RA medications semaglutide and tirzepatide, commonly known by brand names Ozempic, Wegovy, Mounjaro, and Zepbound are associated with lower risks of emergency department visits and hospitalizations related to alcohol use
The most common side effects are mild and transient: water retention, tingling or numbness (most often in the hands), and occasional fatigue or headache shortly after injection